EPISODE · May 11, 2015 · 7 MIN
Androgen Deprivation Therapy for Prostate Cancer - Friend or Foe to the Psyche?
from Journal of Clinical Oncology (JCO) Podcast · host Susan F. Slovin
This is a well-annotated study demonstrating that men treated with androgen deprivation therapy for prostate cancer have impaired cognitive performance within six months of starting therapy and that a specific genetic polymorphism may lend toward greater susceptibility to cognitive impairment.
Embed this episode
Ready to play
Androgen Deprivation Therapy for Prostate Cancer - Friend or Foe to the Psyche?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.